Introduction {#sec1-1}
============

In Ayurveda, "*Karana-Karya Siddhanta*" (cause-effect theory) is considered as one of the most important *Siddhanta* (principle) and for the practical approach *Shad Karanas* (six causative factors viz., *Samanya*, *Vishesha*, *Guna*, *Dravya*, *Karma* and *Samavaya*) are considered as *Karana* (cause) and *Dhatusamya* (equilibrium of body elements) is accepted as *Karya* (effect).\[[@ref1]\] *Samavaya* (inherent relation) being the sixth *Karana* among these, also useful in the field of *Chikitsa* (treatment).\[[@ref2]\]

*Samavaya* is defined as the inseparable relation between *Dravya* (substance) and *Guna* (property).\[[@ref3]\] It is also considered as the inherent relationship between the *Karana* and *Karya*; due to which one understands "this is in that".\[[@ref4]\] *Samavaya* is said to be present in five pairs viz., *Avayava-Avayavi* (whole and its parts), *Guna-Guni* (substance and its property), *Karma-Karmavan* (object and its motion), *Vyakti-Jati* (individual and its class) and *Vishesha-Nityadravya* (particularity and eternal substances).\[[@ref3]\]

In clinical practice while prescribing the medicine to the patient physician always keeps in mind that which properties are going to remain permanently in the particular drug which is intended for use. In the diagnostic field also one has to depend upon the *Pratyatma Lakshanas* (cardinal symptoms) which are inseparably concerned with the particular disease. So here in both the context *Samavaya* is an unavoidable cause as it provides the knowledge of relation between *Dravya*, *Guna* and *Karma* (action).

*Ama* is a unique concept of Ayurveda and plays an important role in vitiation of *Dosha* and occurrence of diseases. *Ama* has the properties such as *Guru* (heavy), *Snigdha* (unctous), *Picchila* (stickey), *Tantu* (forming threads), *Avipakva* (undigested), *Asamyukta* (uncombined), Anekavarna (different colours), Durgandha (foul smell) etc., which are considered as *Samavayatvena* (inherently) present in it.\[[@ref5][@ref6]\] It has been selected here for the applied study considering the *Samavaya* relation between *Dravya* and *Guna* as well as between *Vyadhi* (disease) and its *Lakshanas* (symptoms). *Pippalimula* (roots of *Piper longum* Linn.) was chosen as a drug for the clinical study since it is a drug of choice among all the drugs having *Deepaniya* (appetizer) and *Pachaniya* (digestive) properties.\[[@ref7]\] It has mentioned in the classics that *Pippalimula* possesses *Laghu* (light), *Ushna* (hot) and *Ruksha* (dry) properties which are present in *Samavaya* relation.\[[@ref8]\]

Hence the clinical study was planned considering the hypothesis that *Ama* should be mitigated by the opposite *Gunas* like *Laghu*, *Ruksha* and *Ushna* which are *Samavayatvena* present in the drug *Pippalimula* while the drug placebo (rice flour) possessing the *Gunas* like *Guru*, *Sheeta* and *Snigdha Samavayatvena* should not be able to relieve the symptoms of *Ama* (undigested food material).\[[@ref9]\] Hence, the present study was carried out with the aim to assess the *Samavaya* relation between *Ama* and its *Hetu* and *Lakshanas* along with Practical evaluation of *Samavaya* by using *Pippalimula* on *Ama*.

Materials and Methods {#sec1-2}
=====================

Patients having the classical signs and symptoms of "*Ama*" attaining the Out-Patient Department and In-Patient Department were selected without any bar of cast, religion, occupation and sex. The study was approved by Institutional Ethics Committee (No. PGT/7-A/Ethics/2010-11/1858; dated on 01/09/2010).

Criteria for selection {#sec2-1}
----------------------

Patients suffering from the state of *Ama*Patients of age between 20 and 60 years.

Criteria for exclusion {#sec2-2}
----------------------

Patients of age \<20 years and \>60 yearsPatients having the condition of "*Samshrishta Dosha*" (chronic stage)Patients having any major systemic diseasePatients having the dominancy of "*Pitta Prakriti*".

Grouping and sampling {#sec2-3}
---------------------

Patients were randomly divided into two groups as:

Group A: Tablets (500 mg each) of *Pippalimula Churna* (*P. longum* root powder) has been provided

Group B: Tablets (500 mg each) of rice flour (placebo) has been provided \[[Table 1](#T1){ref-type="table"}\].

###### 

Drug and posology
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Investigations {#sec2-4}
--------------

Routine pathological tests such as blood, urine, stool etc., has been carried out to assess the actual status of the patients and to rule out any pathology.

Criteria for assessment {#sec2-5}
-----------------------

The result was assessed on relief of the signs and symptoms of the disease.\[[@ref10][@ref11]\] The sign and symptoms were *Aruchi* (aversion), *Avipaka* (indigestion), *Udaragaurava* (heaviness of abdomen), *Kshudhanasha* (dyspepsia), *Tandra* (lassitude), *Hrillasa* (nausea), *Alasya* (idleness), *Gurugatrata* (heaviness in body), *Bahumutrata* (polyuria), *Malasamata* (sticky stool) and decrease in *Abhyavaharana* and *Jarana Shakti* (slowness of hunger and digestion). The patient\'s sign and symptoms were noticed before and After treatment with scoring pattern depending upon their severities.\[[@ref12]\]

Assessment of result {#sec2-6}
--------------------

Overall percentage of improvement of each patient was calculated by the formula
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Paired *t*-test was carried out at each symptom individually in both groups, whereas unpaired *t*-test was applied to study the comparative results of both groups at the level of *P* \< 0.05, *P* \< 0.01 and *P* \< 0.001 levels. The obtained results were interpreted as:

Insignificant: *P* \>0.05, Significant: *P* \<0.05 or *P* \< 0.01, Highly significant: *P* \<0.001.

Total effect of therapies {#sec2-7}
-------------------------

Complete remission 100% reliefMarked improvement 75-100% reliefModerate improvement 50-75% reliefMild improvement 25-50% reliefUnchanged 0-25% relief

Observations {#sec1-3}
============

A total of 23 patients were registered in the present study out of which 13 patients were in Group A and 10 were in Group B.

In the present study, 100% patients were suffering from *Avipaka*, *Udaragaurava* and *Ksudhanasha* while *Aruchi* was present in 95.62% patients. Maximum 91.30% patients were having *Alasya* as associated complaint whereas *Tandra* was found present in 79.91% patients. 60.87% and 56.52% patients were suffering from *Gurugatrata* and *Hrillasa* respectively. It has been observed that 91.30% patients were having *Mandagni* while *Vishamagni* was found in 8.70% patients.

*Madhyama* and *Avara Abhyavaharana Shakti* was found in 69.56% and 26.09% patients respectively whereas 65.22% and 34.78% patients were having *Avara* and *Madhyama Jarana Shakti* respectively.

Irregular and *Picchila Malapravritti* were found in 69.57% and 52.17% patients respectively whereas 82.61% patients were having unsatisfactory evacuation of their bowel.

According to the data *Atiguru* and *Atiruksha Ahara* found in 69.57% and 43.48% patients whereas habit of *Adhyashana* (eating before the last meal is digested), *Vishamashana* (irregular eating) and *Atimatrashana* (over eating) was found in 47.83%, 43.48% and 39.13% patients respectively.

The data also showed that 52.17% patients were drinking water in more quantity while 65.22% patients were drinking excess water after consuming the food.

*Divaswapa* (sleep by day), *Vegavidharana* (suppression of natural urges) and *Chinta* (stress) were found as causative factors in 78.26%, 43.48% and 62.21% patients respectively.

Results {#sec1-4}
=======

Effect of therapy in Group A {#sec2-8}
----------------------------

In the present study, maximum 94.44% relief was observed in *Avipaka* whereas *Kshudhanasha*, *Udaragaurava* and *Aruchi* were reduced by 83.73%, 82.85% and 76% respectively. Statistically all the parameters of chief complaints showed highly significant results (*P* \< 0.001) \[[Table 2](#T2){ref-type="table"}\].

###### 

Effect of *Pippalimula* on chief complaints in Group A

![](AYU-35-35-g004)

The data revealed that maximum 100% relief found in *Bahumutrata* followed by 91.67% in *Gurugatra*, 90.92% in *Tandra*, 88.23% in *Hrillasa* and 81.48% relief was observed in *Alasya*. Statistically *Alasya* (*P* \< 0.001) and *Tandra* (*P* \< 0.001) showed highly significant results while *Hrillasa* (*P* \< 0.01) and *Gurugatrata* (*P* \< 0.01) showed significant results. *Bahumutrata* showed insignificant result (*P* \> 0.05) \[[Table 3](#T3){ref-type="table"}\].

###### 

Effect of *Pippalimula* on associated complaints in Group A
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Further in Group A *Malasamata* reduced by 85.26% whereas *Abhyavaharana Shakti* and *Jarana Shakti* increased by 83.64% and 82.50% respectively. Statistically all the parameters showed highly significant results (*P* \< 0.001) \[[Table 4](#T4){ref-type="table"}\].

###### 

Effect of *Pippalimula* on *Agni* and *Malasamata* in Group A
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Effect of therapy in Group B {#sec2-9}
----------------------------

In Group B maximum 46.83% relief found in *Avipaka* while *Aruchi*, *Udaragaurava* and *Kshudhanasha* were reduced by 38.09%, 37.50% and 24.64% respectively. Statistically *Udaragaurava* (*P* \< 0.001) and *Kshudhanasha* (*P* \< 0.001) showed highly significant result, whereas *Aruchi* (*P* \< 0.01) and *Avipaka* (*P* \< 0.01) showed significant results \[[Table 5](#T5){ref-type="table"}\].

###### 

Effect of placebo on chief complaints in Group B
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In Group B the data reveals that maximum 47.09% relief observed in *Tandra* followed by 44.44% in *Hrillasa*, 37.50% in *Gurugatrata*, 23.52% in *Alasya* and 16.67% relief in *Bahumutrata* \[[Table 6](#T6){ref-type="table"}\].

###### 

Effect of Placebo on associated complaints in Group B
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Further *Jarana Shakti* and *Abhyavaharana Shakti* found increased by 27.71% and 27.38% respectively whereas *Malasamata* reduced by 33.33% \[[Table 7](#T7){ref-type="table"}\].

###### 

Effect of Placebo on *Agni* and *Malasamata* in Group B
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Comparative effect of therapy in both the groups {#sec2-10}
------------------------------------------------

Comparatively Group A showed statistically highly significant results in *Avipaka* (*P* \< 0.001), *Udaragaurava* (*P* \< 0.001), *Kshudhanasha* (*P* \< 0.001), *Alasya* (*P* \< 0.001) and *Tandra* (*P* \< 0.001) whereas significant results in *Aruchi* (*P* \< 0.01), *Hrillasa* (*P* \< 0.01), *Gurugatrata* (*P* \< 0.01) and *Bahumutrata* (*P* \< 0.01) than Group B. In *Abhyavaharana Shakti*, *Jarana Shakti* and *Malasamata* also Group A showed statistically highly significant results compared with Group B (*P* \< 0.001) \[Tables [8](#T8){ref-type="table"} and [9](#T9){ref-type="table"}\].

###### 

Comparative effect of therapy on chief and associated complaints in both groups
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###### 

Comparative effect of therapy on *Agni* and *Malasamata* in both groups
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Total effect of therapies {#sec2-11}
-------------------------

Maximum 100% patients showed marked relief in Group A whereas 80% patients in Group B showed mild improvement and 20% patients unchanged \[[Table 10](#T10){ref-type="table"}\].

###### 

Total effect of therapy
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Discussion {#sec1-5}
==========

The cardinal symptoms of *Ama* like *Aruchi*, *Avipaka*, *Udaragaurava* and *Kshudhanasha* were found present in almost all the patients who show the presence of *Samavaya* relation between "*Ama*" and these symptoms. Further the presence of associated symptoms indicates that *Ama* is the base of all these symptoms. *Agnimandya* is the prior state for production of *Ama*\[[@ref13]\] and in case of *Vishamagni* it is mentioned that sometimes it digests the heavy food and occasionally unable to digest proper or less food also and hence it leads to the production of *Ama*.\[[@ref14]\] Here *Samavaya* relation is applicable in between *Agnimandya* and *Ama* which are *Karana* and *Karya* respectively. In *Ama* condition presence of *Agnimandya* and *Udaragaurava* leads to aversion towards the food and one feels satisfied with lesser quantity of food which results into a reduction in *Abhyavaharana Shakti*.\[[@ref15]\] Further due to inadequate and feeble *Agni* the food consumed also not get properly digested, i.e. the *Jarana Shakti* also gets hampered. The properties of *Ama* like *Guru*, *Picchila*, *Snigdha* etc., reflects in the stool as *Picchila* (sticky), i.e. *Sama Malapravritti* and due to its sticky nature it adheres in *Mahasrotasa* making various difficulties in the bowel habits.

*Atiguru Ahara* qualitatively while *Atimatrashana* and *Adhyashana* quantitatively becomes load over *Agni*, hence are responsible for *Agnimandya* and *Ama*.\[[@ref16]\] *Ajirnashana* and *Vishamashana* directly causes the vitiation of *Agni* up to the extent that even the *Laghu Ahara* is not digested properly and becomes *Visharupa* (Poisonous), i.e. *Ama*.\[[@ref17]\] Drinking excess amount of water causes trouble in the digestion process which ultimately causes *Ama*.\[[@ref18]\] *Divasvapa* leads to *Kapha-Pitta Vriddhi* due to which *Agnimandya* occurs or the food consumed doesn't digest properly causing *Ama* production.\[[@ref19]\] Habit of *Vegavidharana* leads to vitiation of *Apana Vayu* which in turn disturbs the function of *Samana Vayu*. Due to this the process of digestion gets hampered, ultimately leading to the production of *Ama*.\[[@ref20]\] *Chinta* is directly mentioned as the causative factor for the production of *Ama*.\[[@ref21]\] A person suffering from stress usually doesn't follow the *Aharavidhividhana* and consumes more or less food, without giving due concentration (*Tanmana Bhunjita*), which leads to indigestion and production of *Ama*.\[[@ref22]\] All these causative factors work as *Karana* for the production of *Ama* (*Karya*). Hence a *Samavaya* relation is established between these *Karanas* (*Hetu*) and *Ama*.

In Group A, due to the presence of *Ushna*, *Laghu* and *Ruksha* properties *Samavayatvena* in the drug *Pippalimula*, it mitigates the *Guru*, *Snigdha*, *Picchila* properties of *Ama*. Hence all the chief and associated complaints got relieved. The *Agnidipaka* action of *Pippalimula* helped to increase the *Abhyavaharana* and *Jarana Shakti*. Furhter due to the *Amapachaka* action *Malasamata* got completely eradicated. In Group B, the absence of *Ushna*, *Laghu*, *Ruksha* properties in placebo makes it incapable to act on *Ama*. Hence, the *Amapachana* did not occur completely in this group. Some amount of results in Group B was due to the presence of luke warm water given as *Anupana* and also due to the general instructions of "*Pathyapathya*" (diet regimen) and "*Nidanaparivarjana*" (avoidance of causative factors) in both the groups.

All these results proved the *Samavaya* relation between *Laghu*, *Ruksha*, *Ushna Guna* and *Pippalimula* and further it also indicates that such kind of relation is absent in placebo.

Conclusion {#sec1-6}
==========

Based on the above study concluded it can be concluded that directly or indirectly everything in this universe depends on *Samavaya* and hence its presence is inevitable in every concept of Ayurveda. Each and every *Dravya* in this universe possesses *Guna* and *Karma Samavayatvena* likewise *Aushadha* and its *Gunakarma*, *Vyadhi* and its *Lakshana* are related with each other by *Samavaya*. The relation of *Pippalimula* and *Ushna*, *Ruksha*, *Laghu Guna* is a type of *Guna-Guni samavaya* and similarly the relation between *Ama* and its properties like *Guru*, *Snigdha*, *Picchila* etc., also taken as *Guna-Guni* kind of *Samavaya*. Further, the relation of *Ama* and its symptoms like *Aruchi*, *Avipaka* and *Udaragaurava* etc., comes under the category of *Karma-Karmavan Samavaya*. On the basis of observations and results it is opined that, *Pippalimula* having *Laghu*, *Ruksha* and *Ushna* properties *Samavayatvena* in it, mitigated the symptoms of *Ama*; which proved the *Samavaya* relation between *Dravya* and *Guna* as well as between *Vyadhi* and its *Lakshanas*.
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